Treatment recommendations for migraine
Stephen D Silberstein
Correspondence Thomas Jefferson University Hospital, 111 South 11th Street, Philadelphia, PA 19107, USA
Email stephen.silberstein@jefferson.edu
Migraine is a common neurological disorder, which, according to figures from US population studies, affects around 18% of women and 6% of men. In this Review, Stephen Silberstein highlights the approach to acute and preventive migraine treatment in the US, drawing on his own experiences at the Headache Center at Thomas Jefferson University Hospital.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$32 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
From CSD to headache: A long and winding roadNature Medicine News and Views (01 Feb 2002)
RESEARCH
G Protein b3 Polymorphism and Triptan Response in Cluster HeadacheClinical Pharmacology & Therapeutics Article Response
See all 6 matches for Research